Immunotherapy News and Research

Latest Immunotherapy News and Research

Fibrinogen-like protein 1 plays dual role in liver regeneration and hepatocellular carcinoma recurrence

Fibrinogen-like protein 1 plays dual role in liver regeneration and hepatocellular carcinoma recurrence

Engineered E. coli optimizes targeted tumor cell killing and improves biosafety

Engineered E. coli optimizes targeted tumor cell killing and improves biosafety

Research paves way for new forms of immunotherapy to treat people with Merkel cell cancer

Research paves way for new forms of immunotherapy to treat people with Merkel cell cancer

Researchers develop advanced method to analyze liquid biopsies of DNA fragments in the blood

Researchers develop advanced method to analyze liquid biopsies of DNA fragments in the blood

Live biotherapeutic product can improve clinical outcomes for patients with kidney cancer

Live biotherapeutic product can improve clinical outcomes for patients with kidney cancer

Using liver biopsies to identify predictors of pancreatic cancer metastasis

Using liver biopsies to identify predictors of pancreatic cancer metastasis

Experts publish guidance to help safely and equitably implement Palforzia peanut oral immunotherapy

Experts publish guidance to help safely and equitably implement Palforzia peanut oral immunotherapy

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

Enhancing adoptive T-cell therapy with nanowire innovation

Enhancing adoptive T-cell therapy with nanowire innovation

JAK1 inhibition and Anti-PD1 therapy enhance outcomes in advanced lung cancer

JAK1 inhibition and Anti-PD1 therapy enhance outcomes in advanced lung cancer

Combination therapy shows great promise as a new strategy against advanced lung cancer

Combination therapy shows great promise as a new strategy against advanced lung cancer

Combining JAK inhibitors with checkpoint inhibitors improves cancer immunotherapy response

Combining JAK inhibitors with checkpoint inhibitors improves cancer immunotherapy response

JAK inhibitor ruxolitinib enhances immunotherapy in Hodgkin lymphoma patients

JAK inhibitor ruxolitinib enhances immunotherapy in Hodgkin lymphoma patients

Timing of melanoma metastasis: Critical implications for treatment

Timing of melanoma metastasis: Critical implications for treatment

New hope for GI cancers: Review analyzes molecular targets and treatment advancements

New hope for GI cancers: Review analyzes molecular targets and treatment advancements

Revolutionary anti-ceramide immunotherapy could prevent blindness in diabetic patients

Revolutionary anti-ceramide immunotherapy could prevent blindness in diabetic patients

AI-based liquid biopsy technology promises early detection of cancer recurrence

AI-based liquid biopsy technology promises early detection of cancer recurrence

New armored CAR T cell therapy boosts response in Relapsed non-Hodgkin lymphoma patients

New armored CAR T cell therapy boosts response in Relapsed non-Hodgkin lymphoma patients

New research sheds light on IL-23's role in chronic inflammatory bowel diseases

New research sheds light on IL-23's role in chronic inflammatory bowel diseases

Macrophages play an unexpected role in the complicated obesity-cancer connection

Macrophages play an unexpected role in the complicated obesity-cancer connection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.